Perioperative chemotherapy for primary sarcoma of bone

K. W. Chan, M. Knowling, C. P. Beauchamp

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


Preoperative chemotherapy for primary osteosarcoma has usually been accompanied by a prolonged delay between withdrawal before operation and resumption after. This is because animal studies showed impaired wound healing associated with perioperative chemotherapy. Clinical studies, however, have not shown this to be the case. The authors describe their experience in eight patients who had osteosarcoma and Ewing's sarcoma of the extremities and received one to three cycles of chemotherapy preoperatively. Chemotherapy consisted of Adriamycin, cis-platinum and vincristine. Definitive surgery on the primary tumour was done 1 to 4 days after the last dose. Amputation was performed on seven patients and tumour resection for limb salvage on one. No wound healing or infectious complications were encountered. The ensuing course of chemotherapy was not delayed by the surgical procedure. The authors conclude that it is feasible to combine neoadjuvant chemotherapy and early surgery in the management of high-grade primary bone sarcoma.

Original languageEnglish (US)
Pages (from-to)43-46
Number of pages4
JournalCanadian Journal of Surgery
Issue number1
StatePublished - 1989

ASJC Scopus subject areas

  • Surgery


Dive into the research topics of 'Perioperative chemotherapy for primary sarcoma of bone'. Together they form a unique fingerprint.

Cite this